European Society of Vascular Medicine @ESVM_ · Oct 10, Oct 10, 2026, 7:02 AM Oral PCSK9 Inhibitor Enlicitide VersusOral Nonstatin Therapiesdoi.org/10.1016/j.jacc…#VascularMedicine
European Society of Vascular Medicine @ESVM_ · Oct 3, Oct 3, 2026, 2:07 PM Recurrent venous thromboembolism and bleeding during anticoagulationin patients with deep-vein thrombosis treated with vitamin K antagonists ordirect oral anticoagulants: insights from the RIETE registry #VascularMedicine
European Society of Vascular Medicine @ESVM_ · Jun 13, Jun 13, 2026, 10:12 AM Do women with venous thromboembolismbleed more than men duringanticoagulation? Data from the real-life,prospective START-Registerdoi.org/10.1177/204209…doi.org/10.1177/2042098
European Society of Vascular Medicine @ESVM_ · Jun 6, Jun 6, 2026, 7:13 PM Quantifying treatment effect: relative and absolute measures in clinicalresearchdoi:10.4081/itjm.2026.2386
European Society of Vascular Medicine @ESVM_ · May 30, May 30, 2026, 10:21 AM Categorization of patients with peripheral artery disease by Charlson Comorbidity Index#VascularMedicinedoi.org/10.1093/eurjpc…